Blank CU - Search Results

1

Phase Ib/II trial testing combined radiofrequency ablation and ipilimumab in uveal melanoma (SECIRA-UM).

Rozeman EA, Prevoo W, Meier MAJ, Sikorska K, Van TM, van de Wiel BA, van der Wal JE, Mallo HA, Grijpink-Ongering LG, Broeks A, Lalezari F, Reeves J, Warren S, van Thienen JV, van Tinteren H, Haanen JBAG, Kapiteijn E, Blank CU. Rozeman EA, et al. Among authors: blank cu. Melanoma Res. 2020 Jun;30(3):252-260. doi: 10.1097/CMR.0000000000000653. Melanoma Res. 2020. PMID: 31895753 Clinical Trial.

2

Neoadjuvant sunitinib for surgically complex advanced renal cell cancer of doubtful resectability: initial experience with downsizing to reconsider cytoreductive surgery.

Bex A, van der Veldt AA, Blank C, van den Eertwegh AJ, Boven E, Horenblas S, Haanen J. Bex A, et al. World J Urol. 2009 Aug;27(4):533-9. doi: 10.1007/s00345-008-0368-7. Epub 2009 Jan 15. World J Urol. 2009. PMID: 19145434

3

Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimers.

Hadrup SR, Bakker AH, Shu CJ, Andersen RS, van Veluw J, Hombrink P, Castermans E, Thor Straten P, Blank C, Haanen JB, Heemskerk MH, Schumacher TN. Hadrup SR, et al. Nat Methods. 2009 Jul;6(7):520-6. doi: 10.1038/nmeth.1345. Epub 2009 Jun 21. Nat Methods. 2009. PMID: 19543285

4

Progression of a caval vein thrombus in two patients with primary renal cell carcinoma on pretreatment with sunitinib.

Bex A, Van der Veldt AA, Blank C, Meijerink MR, Boven E, Haanen JB. Bex A, et al. Acta Oncol. 2010 May;49(4):520-3. doi: 10.3109/02841860903521111. Acta Oncol. 2010. PMID: 20105087 No abstract available.

5

RNA interference targeting programmed death receptor-1 improves immune functions of tumor-specific T cells.

Borkner L, Kaiser A, van de Kasteele W, Andreesen R, Mackensen A, Haanen JB, Schumacher TN, Blank C. Borkner L, et al. Cancer Immunol Immunother. 2010 Aug;59(8):1173-83. doi: 10.1007/s00262-010-0842-0. Epub 2010 Mar 27. Cancer Immunol Immunother. 2010. PMID: 20349059 Free PMC article.

6

The safety and efficacy of sunitinib before planned nephrectomy in metastatic clear cell renal cancer.

Powles T, Kayani I, Blank C, Chowdhury S, Horenblas S, Peters J, Shamash J, Sarwar N, Boletti K, Sadev A, O'Brien T, Berney D, Beltran L, Haanen J, Bex A. Powles T, et al. Ann Oncol. 2011 May;22(5):1041-1047. doi: 10.1093/annonc/mdq564. Epub 2011 Jan 17. Ann Oncol. 2011. PMID: 21242586 Free PMC article. Clinical Trial.

7

Overall survival and PD-L1 expression in metastasized malignant melanoma.

Gadiot J, Hooijkaas AI, Kaiser AD, van Tinteren H, van Boven H, Blank C. Gadiot J, et al. Cancer. 2011 May 15;117(10):2192-201. doi: 10.1002/cncr.25747. Epub 2010 Nov 29. Cancer. 2011. PMID: 21523733 Free article.

8

A phase II study of presurgical sunitinib in patients with metastatic clear-cell renal carcinoma and the primary tumor in situ.

Bex A, Blank C, Meinhardt W, van Tinteren H, Horenblas S, Haanen J. Bex A, et al. Urology. 2011 Oct;78(4):832-7. doi: 10.1016/j.urology.2011.05.034. Epub 2011 Jul 29. Urology. 2011. PMID: 21802123 Clinical Trial.

9

Combination of targeted therapy and immunotherapy in melanoma.

Blank CU, Hooijkaas AI, Haanen JB, Schumacher TN. Blank CU, et al. Cancer Immunol Immunother. 2011 Oct;60(10):1359-71. doi: 10.1007/s00262-011-1079-2. Epub 2011 Aug 17. Cancer Immunol Immunother. 2011. PMID: 21847631 Free PMC article. Review.

10

Expression of the embryological morphogen Nodal in stage III/IV melanoma.

Hooijkaas AI, Gadiot J, van Boven H, Blank C. Hooijkaas AI, et al. Melanoma Res. 2011 Dec;21(6):491-501. doi: 10.1097/CMR.0b013e32834bf37b. Melanoma Res. 2011. PMID: 22002671

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

324 results

Search Page

Filters